OSLM
Outcome Studies
in Laboratory Medicine
guest
👤
Learn more about this platform
c
Categories
p
Projects
Highlighted
Trial protocol
Study Design
RCT
Cluster RCT
Observational
Model
Meta-analysis
Review
Guideline
Outcomes
Change patient management
Clinical outcomes
Economics
Operational efficiencies
Patient-centeredness
Safety
Guide Policy Making
Other
Uncategorized
Antibiotic Guidance
ACT Guided Heparinization
Cancer
COVID-19
Cardiovascular Disease
Diabetes
HIV POCT
Inflammatory Bowel Disease
Liver Disease
Kidney Disease
Newborn Screening
MALDI-TOF MS For Microorganism Identification
Preeclampsia
Pharmacogenetic and Pharmacogenomics
Therapeutic drug monitoring
Viscoelastic Testing
Please contact us for any suggestions
Zhen Zhao
Smeralda Skenderaj
Search
Search
1306 Publications
found
Trough concentrations of infliximab guide dosing for patients with inflammatory bowel disease.
b
Gastroenterology
June 1, 2015
p
Therapeutic drug monitoring
c
Change patient management
Clinical outcomes
RCT
High-sensitivity troponin assays for the early rule-out or diagnosis of acute myocardial infarction in people with acute chest pain: a systematic review and cost-effectiveness analysis.
b
Health technology assessment (Winchester, England)
June 1, 2015
p
Cardiovascular Disease
c
Economics
Model
Systematic neonatal screening for severe combined immunodeficiency and severe T-cell lymphopenia: Analysis of cost-effectiveness based on French real field data.
b
The Journal of allergy and clinical immunology
June 1, 2015
p
Newborn Screening
c
Economics
Observational
Magnitude of troponin elevation and long-term clinical outcomes in acute coronary syndrome patients treated with and without revascularization.
b
Circulation. Cardiovascular interventions
June 1, 2015
p
Cardiovascular Disease
c
Clinical outcomes
RCT
Potential public health benefits of HIV testing occurring at home in Australia.
b
The Medical journal of Australia
June 1, 2015
p
HIV POCT
c
Review
Feasibility of implementing molecular-guided therapy for the treatment of patients with relapsed or refractory neuroblastoma.
b
Cancer medicine
June 1, 2015
p
Cancer
c
Change patient management
Clinical outcomes
Observational
Outcome and economic implications of proteomic test-guided second- or third-line treatment for advanced non-small cell lung cancer: extended analysis of the PROSE trial.
b
Lung cancer (Amsterdam, Netherlands)
May 1, 2015
p
Cancer
c
Clinical outcomes
Economics
Model
C-reactive protein as a single useful parameter for discontinuation of antibiotic treatment in Thai neonates with clinical sepsis.
b
Journal of the Medical Association of Thailand = Chotmaihet thangphaet
April 1, 2015
p
Antibiotic Guidance
c
Change patient management
Clinical outcomes
RCT
Cardiac troponin and C-reactive protein for predicting all-cause and cardiovascular mortality in patients with chronic kidney disease: a meta-analysis.
b
Clinics (Sao Paulo, Brazil)
April 1, 2015
p
Cardiovascular Disease
c
Clinical outcomes
Meta-analysis
Review
Cost-effectiveness of multiplexed predictive biomarker screening in non-small-cell lung cancer.
b
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
April 1, 2015
p
Cancer
c
Economics
Model
Previous Page
1
…
104
105
106
107
108
…
131
Next Page